Aromatic: — Other: — Drugs
Part of: 293190 — Other:
N292267 · 2017-12-12 — The tariff classification of Ixazomib (CAS No. 1072833-77-2) in bulk powder form, from Taiwan
The subject product, Ixazomib, is a proteasome inhibitor that is indicated in combination with other drugs for the treatment of multiple myeloma, which is a type of white blood cell cancer. The applicable subheading for the Ixazomib in bulk powder form will be 2931.90.2200, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Other organo-inorganic compounds: Other: Aromatic: Other: Drugs.” The rate of duty will be 6.5 percent ad valorem. Currently, Ixazomib is not listed in the Pharmaceutical Appendix to the Tariff Schedule. Duty rates are provided for your…
N282326 · 2017-03-16 — The tariff classification of Ixazomib Citrate (CAS No. 1239908-20-3) in bulk powder form, from Taiwan
, you requested a tariff classification ruling. We apologize for the delay as the information was sent to our laboratory for analysis. The subject product, Ixazomib Citrate, is a proteasome inhibitor that will be imported in bulk powder form. It is indicated for the treatment of multiple myeloma. The applicable subheading for the Ixazomib Citrate in bulk powder form will be 2931.90.2200, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Other organo-inorganic compounds: Other: Aromatic: Other: Drugs.” The rate of duty will be 6.5 percent ad valorem. Currently,…
Not sure this code fits your product? HaiLang AI determines the US HTS code from a description in about a minute.
Classify a product